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ABSTRACT
Purpose: The aim of the present study was to retrospectively investigate the influence of 
potential risk indicators on the development of peri-implant disease.
Methods: Overall, 103 patients referred for implant treatment from 2000 to 2012 were 
randomly enrolled. The study sample consisted of 421 conventional-length (>6 mm) non-
turned titanium implants that were evaluated clinically and radiographically according to pre-
established clinical and patient-related parameters by a single investigator. A non-parametric 
Mann-Whitney U test or Kruskal-Wallis rank test and a logistic regression model were used 
for the statistical analysis of the recorded data at the implant level.
Results: The diagnosis of peri-implant mucositis and peri-implantitis was made for 
173 (41.1%) and 19 (4.5%) implants, respectively. Age (≥65 years), patient adherence 
(professional hygiene recalls <2/year) and the presence of plaque were associated with higher 
peri-implant probing-depth values and bleeding-on-probing scores. The logistic regression 
analysis indicated that age (P=0.001), patient adherence (P=0.03), the absence of keratinized 
tissue (P=0.03), implants placed in pristine bone (P=0.04), and the presence of peri-implant 
soft-tissue recession (P=0.000) were strongly associated with the event of peri-implantitis.
Conclusions: Within the limitations of this study, patients aged ≥65 years and non-adherent 
subjects were more prone to develop peri-implant disease. Therefore, early diagnosis and 
a systematic maintenance-care program are essential for maintaining peri-implant tissue 
health, especially in older patients.
Keywords: Dental implants; Implant-supported dental prosthesis; Periodontal diseases; 
Peri-implantitis; Retrospective study; Risk factors
INTRODUCTION
Peri-implant mucositis and peri-implantitis can be categorized as biological complications in 
implant rehabilitation. Peri-implant mucositis has been defined as a reversible inflammatory 
reaction of peri-implant soft tissues with no radiographic evidence of bone loss [1]. From 
a clinical perspective, signs that determine the presence of peri-implant mucositis include 
erythema and swelling, usually associated with probing depths ≥4 mm [2,3]; however, the 
essential parameter for diagnosis is bleeding on gentle probing (<0.25 N) [4]. In contrast, 
peri-implantitis has been identified as a progressive and irreversible infectious pathological 
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condition associated with changes in the level of crestal bone, the presence of bleeding on 
probing (BOP), and/or suppuration with or without concomitant deepening of the peri-
implant pockets around an osseointegrated implant in function [4,5]. Although these are 
typical signs, sometimes they are not clearly recognizable. Furthermore, the predictive value 
of BOP, increased peri-implant probing depth (PPD), or peri-implant bone loss (PBL) as 
individual features remains insufficiently well established [6]. Despite this, the presence of 
BOP, PPD, and PBL have been associated with peri-implant lesions when evaluated in the 
context of specific patient- and site-dependent variables, including age, gender, smoking, 
adherence to oral hygiene procedures, gingival biotype, the presence of plaque, keratinized 
tissue and soft tissue recessions, and the type of bone graft and membrane during the 
implant placement [7-9]. Etiologically, other factors and conditions may contribute to 
the development of peri-implant disease, including alcohol consumption, a history of 
periodontitis, residual cement, bacterial micro-leakage at the implant abutment interface, 
implant surface characteristics, the type of the prosthetic supra-structure, osteoporosis, 
and diabetes [10,11]. A risk factor has been described as “an environmental, behavioral, or 
biological factor that, if present, directly increases the probability of a disease (or adverse 
event) occurring and, if absent or removed, reduces that probability. Risk factors are part of 
the causal chain, or expose the host to the causal chain,” [12] whereas a risk indicator may 
be defined as a “probable risk factor that has not been confirmed by carefully conducted 
longitudinal studies” [12]. Because there is increasing evidence to suggest that peri-implant 
mucositis is the precursor of peri-implantitis, early detection of risk factors plays a key role 
in preventing further progression of the disease. Despite the fact that prospective studies 
are essential to assess true risk factors, retrospective and cross-sectional studies may be 
suitable to identify risk indicators for the disease [13]. However, it is difficult to compare the 
analyses of such risk indicators due to heterogeneity between studies in terms of the peri-
implant disease diagnostic criteria, the definitions of implant success, and the reference 
points for measuring the marginal PBL [5,7]. Consequently, the influence of potential clinical 
predictors on the diagnosis and prognosis of peri-implant disease might be inadequately 
reported. Therefore, the purpose of the present retrospective study was to evaluate how 
the presence of different independent implant- and patient-related risk indicators might 
influence the odds of developing a peri-implant disease in a randomized cohort of patients.
MATERIALS AND METHODS
Study design and participants
The study reports on patients treated in a university setting with conventional-length (>6 
mm), non-turned, 2- and 3-piece titanium implants during a period ranging from 2000 
to 2012. A random sample was enrolled of partially and fully edentulous patients with at 
least one implant-supported restoration in occlusal loading during the appointment for 
evaluation. The patients were consecutively included, and the data were collected from July 
2014 to July 2015 during regular implant maintenance visits. Implant surgical operations 
and prosthetic restorations were all performed in the same department (Implant Center for 
Edentulism and Jawbone Atrophies, Maxillofacial Surgery and Odontostomatology Unit, 
Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy). To exclude 
possible operator-dependent bias, clinical measurements were taken by a single blinded 
investigator. Each patient was given a detailed description of the procedure, and informed 
consent was obtained prior to participation in the study. The present cross-sectional study 
was carried out in accordance with the Declaration of Helsinki of ethical human research 
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practices. No ethics committee approval was sought due to the retrospective nature of the 
present study, and such oversight was not required by national law or by ordinance of the 
local inspection authority.
Exclusion criteria
In accordance with Konstantinidis et al. [9] and Schwarz et al. [8], for patient selection, the 
following exclusion criteria were defined: (1) any uncontrolled systemic diseases that could 
influence the implant therapy outcome (e.g., diabetes [HbA1c >7], osteoporosis); (2) any 
intake of medications that may have an effect on bone turnover and mucosal healing (i.e., 
steroids, antiresorptive therapy); (3) any antibiotic treatment for a medical or dental reason 
within the 2 months prior to the examination; (4) any restorations that did not allow for the 
calculation of PPD; (5) inability or refusal to sign the informed consent form; (6) fewer than 
12 months of follow-up post loading; (7) pregnancy or breastfeeding in women; and (8) the 
absence of baseline radiographs taken at the time of placement of the suprastructure.
Anamnestic data and implant site characteristics
The following study variables were assessed: (1) patient age at the time of final examination; 
(2) gender; (3) smoking habits; and (4) patient adherence (PA) (i.e., whether a patient came 
to professional hygiene recall appointments at least every 6 months or at intervals >6 months 
since placement of the suprastructure).
The following implant site characteristics were considered: (1) the bone graft (i.e., whether 
the implant was placed in regenerated bone or in pristine bone) and (2) the presence or 
absence of a membrane covering the graft during the regenerative procedure.
Clinical measurements
The following clinical parameters were assessed at each implant site using a periodontal 
probe (Williams 14W Probe, Hu-Friedy Mfg. Co., Chicago, IL, USA): (1) the gingival biotype 
(direct visual assessment, i.e., visibility of the periodontal probe); (2) the presence (≥1 mm) 
or absence of keratinized tissue (KT) measured as the distance between the peri-implant 
mucosal margin and the muco-gingival junction at the buccal marginal portion of the 
implant mucosa; (3) PPD (measured from the mucosal margin to the probeable pocket); 
(4) BOP; (5) plaque index (PI); and (6) peri-implant recession (REC, defined as the distance 
between the implant shoulder and mucosal margin). The measurements of PI, BOP, and 
PPD were performed at six aspects per implant: mesio-buccal, mid-buccal, disto-buccal, and 
respective lingual/palatal sites. The presence of KT was visually assessed at the mid-facial 
and mid-oral surfaces. When clinical signs (i.e., BOP with or without suppuration) suggested 
the presence of peri-implantitis, non-standardized periapical radiographs were taken at the 
time of the clinical examination with the long cone paralleling technique and film holders 
(Rinn XCP, Dentsply Corporate, York, PA, USA) and compared with a baseline radiograph 
taken at the time of prosthesis installation for bone level confirmation [2]. Particularly, the 
radiographs were scanned to obtain standardized digital images with a resolution of 1,200 
dpi. These images were imported and analyzed using specialized computer software (ImageJ 
v 1.49, Research Services Branch, National Institute of Health, Bethesda, MD, USA). The 
calibration of the pixel/mm ratio was performed using the length of the implant as a fixed 
reference point to compensate for potential radiographic distortion. For the assessment of 
bone loss, the radiographic distance between the implant shoulder level and the most coronal 
bone-to-implant contact level was measured mesially and distally, parallel with the long axis 
of the implant. The same blinded examiner performed all radiographic measurements.
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Case definition
Implants were considered healthy in case of no BOP or bleeding only at one surface, 
assuming one point of bleeding as a consequence of trauma from probing, with no 
suppuration. The presence of peri-implant mucositis was defined by an osseointegrated 
implant presenting BOP from more than one surface area of the implant [14]. The presence 
of peri-implantitis was defined as an osseointegrated implant presenting ≥2 mm peri-
implant marginal bone loss concomitant with BOP and/or pus on probing from at least one 
surface area of the implant, associated with PPD ≥4 mm at the time of examination [5]. The 
measurement of BOP and the presence of suppuration were assessed within 60 seconds of 
measurements of PPD.
Statistical analysis
Data were collected using Excel (Microsoft, Redmond, WA, USA). Statistical analysis was 
performed using SPSS version 22.0 (IBM Corp., Armonk, NY, USA).
The statistical evaluation included the Kolmogorov-Smirnov test to evaluate the normality 
of the distributions. Since the data were not normally distributed, non-parametric tests were 
used for all comparisons, including the Mann-Whitney U test, the Kruskal-Wallis rank test, 
or the Pearson χ2 test, as appropriate. To measure the association between the predictor and 
outcome variable while controlling for confounders, a logistic regression model was used. The 
data were allowed to enter the model using backward selection with the significance level to 
remove set at 0.1. Recorded data are presented as mean values, median (interquartile range; 
IQR) values, or frequencies (%). P-values <0.05 were considered to be statistically significant.
RESULTS
Overall, 62 (60.2%) female patients and 41 (39.8%) male patients aged 26 to 87 years 
(mean, 60±8.6 years) were randomly enrolled. A total of 421 dental implants were inserted, 
244 (58%) into female patients and 116 (42%) into male patients. According to the given 
definition, out of the 421 implants, 173 (41.1%) presented BOP on more than one surface 
area of the implant and were therefore considered affected by a peri-implant mucositis. From 
a deeper analysis by means of periapical X-rays, 19 (4.5%) presented peri-implant marginal 
bone loss, and therefore the diagnosis of peri-implantitis was made.
The descriptive statistics for the sample are summarized in Table 1. When considering the 
PPD, the median value (IQR) was 2.6 mm (1.2 mm). Statistically significant differences 
in probing depths were observed when the measurements were correlated with specific 
independent variables: age, gender, PA, membrane, bone graft, and REC. Clinically, 248 
(58.9%) implants did not present BOP, whereas 173 (41.1%) showed BOP. Differences in BOP 
were statistically significant when the following independent variables were considered: age, 
PA, gingival biotype, PI, and REC.
The logistic regression analysis revealed risk factors for peri-implantitis (Table 2). Overall, 5 
out of 10 independent variables were significant indicators for peri-implantitis: age (P=0.001), 
PA (P=0.03), KT (P=0.03), bone graft (P=0.04), and REC (P=0.000). Odds ratio (OR) estimates 
and 95% confidence intervals (CIs) were retrieved from the intercept of each factor.
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Table 1. The association between the independent variables versus peri-implant probing depth and bleeding on probing
Independent variables Category Total No. of 
implants (%)
Clinical measurements
PPD (mm) BOP
Mean Median (IQR) P-value Yes, No. (%) No, No. (%) P-value
Age (yr) 26–57 136 (32.3) 2.49 2.5 (1.0) 0.036a) 46 (33.8) 90 (66.2) 0.025
58–64 144 (34.2) 2.55 2.6 (1.2) 57 (39.6) 87 (60.4)
65–87 141 (33.5) 2.78 2.6 (0.9) 70 (49.6) 71 (50.4)
Gender Male 177 (42) 2.50 2.5 (1.0) 0.012 72 (40.7) 105 (59.3) 0.880
Female 244 (58) 2.69 2.6 (1.1) 101 (41.4) 143 (58.6)
Smoking Yes 77 (18.3) 2.53 2.6 (1.2) 0.570 32 (41.6) 45 (58.4) 0.930
No 344 (81.7) 2.63 2.6 (1.2) 141 (41.0) 203 (59.0)
Professional oral hygiene recalls 
(mon)
<6 145 (34.4) 2.46 2.5 (1.1) 0.020 50 (34.5) 95 (65.5) 0.046
>6 276 (65.6) 2.69 2.6 (1.0) 123 (44.6) 153 (55.4)
Gingival biotype Thick 309 (73.4) 2.59 2.6 (1.0) 0.490 119 (38.5) 190 (61.5) 0.070
Thin 112 (26.6) 2.67 2.6 (1.2) 54 (48.2) 58 (51.8)
Keratinized tissue Yes 200 (47.5) 2.57 2.5 (1.0) 0.190 74 (37.0) 126 (63.0) 0.100
No 221 (52.5) 2.65 2.6 (1.0) 99 (44.8) 122 (55.2)
Membrane Yes 123 (29.2) 2.48 2.5 (1.4) 0.080 51 (41.5) 72 (58.5) 0.920
No 298 (70.8) 2.66 2.6 (1.0) 122 (40.9) 176 (59.1)
Bone graft Yes 143 (34) 2.46 2.5 (1.4) 0.013 62 (43.4) 81 (56.6) 0.500
No 278 (66) 2.69 2.6 (1.0) 111 (39.9) 167 (60.1)
Plaque Yes 97 (23) 2.78 2.6 (1.0) 0.005 54 (55.7) 43 (44.3) 0.001
No 324 (77) 2.56 2.5 (1.0) 119 (36.7) 205 (63.3)
Peri-implant soft tissue recession Yes 98 (23.3) 2.70 2.6 (1.1) 0.160 53 (54.1) 45 (45.9) 0.003
No 323 (76.7) 2.58 2.5 (1.0) 120 (37.2) 203 (62.8)
Total 421 (100) 2.61 2.6 (1.2) 173 (41.1) 248 (58.9)
Data are presented as mean, median and interquartile range, or frequencies (%).
PPD, peri-implant probing depth; BOP, bleeding on probing; IQR, interquartile range.
a)Post hoc analysis revealed a statistically significant difference between the older patients (the 65–87 age group) and the other groups (P<0.05).
Table 2. The risk indicators for peri-implantitis according to the logistic regression analysis
Independent variables Category Total No. of  
implants (%)
Peri-implantitis OR CI 95% P-value
Yes No
Age (yr) 26–57 136 (32.3) 2 134
58–64 144 (34.2) 3 141 1.80 0.27–12.03 0.550
65–87 141 (33.5) 14 127 14.81 2.85–77.03 0.001a)
Gender Male 177 (42) 7 170 NS
Female 244 (58) 12 232
Smoking Yes 77 (18.3) 3 74 NS
No 344 (81.7) 16 328
Professional oral hygiene recalls (mon) <6 145 (34.4) 3 142
>6 276 (65.6) 16 260 4.69 1.17–18.79 0.030a)
Gingival biotype Thick 309 (73.4) 10 299 NS
Thin 112 (26.6) 9 103
Keratinized tissue Yes 200 (47.5) 5 195
No 221 (52.5) 14 207 3.99 1.15–13.82 0.030a)
Membrane Yes 123 (29.2) 2 121 NS
No 298 (70.8) 17 281
Bone graft Yes 143 (34) 3 140
No 278 (66) 16 262 4.51 1.03–19.64 0.040a)
Plaque Yes 97 (23) 3 94 NS
No 324 (77) 16 308
Peri-implant soft tissue recession Yes 98 (23.3) 13 85 13.09 4.19–40.90 0.000a)
No 323 (76.7) 6 317
Total 421 (100) 19 402
OR, 95% CI, and P-values are reported.
OR, odds ratio; CI, confidence interval; NS, not significant, the independent variable was not a statistically significant predictor of peri-implantitis.
a)Statistically significant difference between the analyzed variables.
DISCUSSION
The present retrospective study was designed to assess the influence of potential risk factors 
on the development of peri-implant disease at the implant level. Because multivariate 
analyses correcting for confounding factors may be indicated in cases of retrospective studies 
assessing peri-implantitis predictors, a logistic regression model was used. Mean prevalences 
of peri-implant mucositis and peri-implantitis at 43% and 22%, respectively, have been 
recently reported [15]. In the present study, prevalences of 41.1% and 4.5% were observed 
for the peri-implant mucositis and peri-implantitis group, respectively. These results 
favorably compare with those reported in a recent meta-analysis, in which the frequency 
of peri-implant mucositis and peri-implantitis were 30.7% and 9.6%, respectively [16]. In 
the present study, the lower peri-implantitis rate was probably related to the selection of a 
convenience sample subjected to the same surgical and prosthetic protocol, which may have 
decreased the prevalence of the event. Moreover, the heterogeneity among studies resulting 
from differences in case definition and study design may have led to an overestimation of the 
frequency of the disease. 
Because many systemic diseases are chronic and more common in older individuals, and can 
directly or indirectly compromise implant health, age may be considered a risk indicator. As 
a confirmation of this hypothesis, the present study indicated that patient age ≥65 years and 
a low level of patient adherence (>6 months per recall appointment) were strongly associated 
with peri-implant mucositis (P=0.025 and P=0.046, respectively) and peri-implantitis 
(OR=14.81; P=0.001 and OR=4.69; P=0.03, respectively). This was also emphasized by the 
significantly higher PPD values measured in the two groups (2.78 mm; P=0.036 and 2.69 
mm; P=0.020, respectively). A similar trend was observed by Ferreira et al. [14] considering a 
study group of 212 partially edentulous subjects rehabilitated with osseointegrated implants. 
The authors found slightly higher prevalences of peri-mucositis and peri-implantitis for 
older individuals (>45 years old) (58.57% vs. 67.60% and 7.14% vs. 9.85%, respectively) and 
for patients who underwent episodic maintenance visits (>6 months) (61.70% vs. 66.95% 
and 8.51% vs. 9.32%, respectively). Peri-mucositis showed a correlation with the age of the 
patients that was also validated by the univariate analysis performed by Roos-Jansaker et 
al., who found that age (≥60 years old) was a significant risk factor for the development of 
the disease (P=0.02). This finding is in agreement with a study regarding prevalence and 
risk variables for peri-implant disease in a comparable cohort sample, which concluded that 
subjects older than 65 years were more prone to develop peri-implantitis [17]. This may be 
explained by several factors, namely difficulties in maintaining proper oral hygiene due to 
impaired vision, lack of dexterity, brain diseases (e.g., Parkinson disease or dementia), and 
osteoarthritis; increased occurrence of cancer that requires radiotherapy treatment, therefore 
enhancing the risk of peri-implantitis; lower immunity, compromised healing capacity, 
and lack of motivation in oral hygiene measures that may arise as a consequence of tooth 
loss [18,19]. Age was also identified as a contributory factor for the development of peri-
implantitis when associated with a history of periodontitis and cardiovascular disease [20]. 
Even the immobility of older patients preventing them from reaching the dental clinic may 
postpone recall hygiene visits, jeopardizing the efficacy of the implant maintenance program 
and thus increasing the risk of peri-implant disease. On the other hand, a recent long-
term retrospective study evaluating implants placed in subjects older than 65 years found a 
failure rate of 4.61% at the implant level and 0.02% at the patient level [21]. Thus, it may be 
suggested that the patient’s age might not represent a factor of major prognostic significance 
in implant treatment, if meticulous oral hygiene procedures and recall visits are respected. 
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Indeed, inadequate plaque control due to poor accessibility for oral hygiene at implant sites 
has been associated with peri-implantitis [22]. 
In the present study, the role of plaque accumulation in terms of increased risk of peri-
implant disease led to contradictory results. Despite the failure to demonstrate a clear 
association between the presence of plaque and peri-implantitis in terms of increased 
risk of susceptibility, statistically significant differences in terms of a higher percentage 
of PPD (P=0.005) and BOP (P=0.001) were found. This was probably related to the great 
heterogeneity within the group with no plaque (n=324) versus the group showing plaque 
(n=97), which in turn led to misleading results. On the other hand, several studies have 
pointed out a positive correlation between high plaque scores and increased risk of 
presenting peri-implant disease [17,22]. The primary role of plaque in disease occurrence was 
also stressed by Ferreira et al. [14], who found a dose-dependent association between higher 
plaque scores and worse conditions in peri-implants. The OR for plaque score in cases of 
peri-implantitis (OR=14.3, 95% CI, 9.1–28.7) was much higher when compared with the same 
level of plaque score in peri-implant mucositis (OR=2.9, 95% CI, 2.0–4.1). In the present 
study, this was corroborated by the higher likelihood of developing peri-implantitis for 
patients who underwent professional oral hygiene recall less than twice a year with respect to 
patients who adhered to the implant maintenance schedule. 
Furthermore, the patient's adherence has a consequent effect on the marginal bone levels. 
Indeed, a lower mean level of bone loss was observed in the adherent group compared with 
the non-responding group [23]. Hence, the role of supportive maintenance care could be 
considered a key factor in reducing the risk of implant complications. Accordingly, the 
absence of preventive maintenance has been associated with significantly worse peri-
implant conditions, in terms of PI, BOP, percentage of sites with PD ≥5 mm, number of 
implants with peri-implantitis, and PBL [24]. Accordingly, data reported in the present 
study confirmed the fact that the worst PPD and BOP scores were significantly associated 
with non-adherent patients.
The correlation between peri-implantitis and the presence or absence of KT deserves some 
discussion. Indeed, the data show a higher incidence of peri-implantitis in patients who 
did not present KT compared with patients presenting with at least 1 mm of KT (OR=3.99; 
P=0.03). There has been controversy in the discussion of the impact of KT around dental 
implants. Soft tissue defects or poor-quality soft tissue at the area of implantation has been 
considered to be a risk factor for the development of peri-implantitis [25]. This is probably 
related to the association of a lack of adequate KT around endosseous dental implants with 
more plaque accumulation, tissue inflammation, mucosal recession, and attachment loss. 
Conversely, similar studies were not able to find a clear association between the absence of 
keratinized peri-implant mucosa and peri-implant disease [7,8,26]. The results obtained in 
the present study corroborated those reported in a recent systematic review, emphasizing 
the importance of an adequate zone of KT surrounding implants so that better peri-implant 
tissue health may be achieved [27]. Interestingly, on the other hand, the presence or absence 
of KT did not influence the likelihood of developing peri-implant mucositis. Thus, one 
may speculate that implants might be maintained in a healthy condition even in cases of an 
inadequate width of KT; however, the absence of KT associated with poor oral hygiene is 
a relevant risk factor for the development of peri-implant disease. This is particularly true 
when patients without keratinized mucosa are categorized as thin-biotype subjects [28]. Our 
statistical analyses indicated that a thin biotype was associated with higher percentages of 
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BOP as compared with thick-biotype patients (38.5% vs. 48.2%, respectively). This result 
can be attributed to thinner tissues being more friable, less vascularized, and accompanied 
with thinner underlying bone. Furthermore, a thin periodontal biotype is associated with 
a more shallow biologic width compared with a thick biotype. As a consequence, a thin 
biotype is more susceptible to biologic width invasion, resulting in marginal tissue recession 
and alveolar bone loss [29]. This is particularly true in cases of dental implants, due to the 
fundamental differences that exist between the peri-implant mucosa and its counterpart 
in natural teeth. Thus, similar to gingival tissue, thin peri-implant soft tissue is more 
susceptible to soft tissue recession compared with thick peri-implant soft tissue. Therefore, 
a thin-tissue biotype associated with missing KT is associated with an increased risk of 
unfavorable treatment outcomes following surgical interventions [30].
This may explain the strong relation between peri-implant soft tissue recession and the 
occurrence of peri-implantitis. The logistic regression model showed a statistically significant 
connection between the presence of REC and peri-implant disease (OR=13.09; P=0.00). 
This might be attributed to the different behavior of the two different biotypes in response 
to mechanical and/or surgical trauma. Indeed, a thick biotype reacts with the formation of 
periodontal pockets and intrabony defects, whereas a thin biotype responds with gingival 
recessions [31]. These results corroborated those of a previous study that reported increased 
soft and hard tissue resorption to re-establish a healthy peri-implant mucosal dimension, 
especially in a thin biotype [32]. This explanation favorably compares with a recent 
observation that the distance between the implant platform level and bone level was greater 
in individuals with peri-implantitis, indicating that soft tissue recession as a consequence 
of bone loss negatively influences peri-implant tissue health [20]. A peri-implant soft 
tissue recession as a consequence of bone loss induced by a peri-implantitis lesion might 
expose the coronal portion of the implant. Moreover, due to a greater tendency for rougher 
surfaces to accumulate and retain more plaque, biofilm formation is facilitated [33]. Thus, 
the relevant correlation between REC and peri-implantitis can also be explained by the fact 
that, for implants with a coronal roughened surface, such as those evaluated in the present 
study, a bacterial biofilm forms upon exposure to the oral environment as a consequence of 
soft tissue recession. Because these microorganisms may persist and proliferate, they are a 
leading contributor to peri-implantitis, which can lead to the loss of implant integration [34]. 
Although rough-surface implants are technically more susceptible to bacterial colonization, 
this has been demonstrated mostly in animal or in vitro studies [35,36]. Evidence for the 
influence of the implant surface characteristics as a risk indicator for peri-implantitis still 
needs further investigation [37].
The role of the recipient bone (native bone vs. grafted bone) in developing peri-implant 
disease is still debated. From the data obtained in the present analysis, implants placed in 
pristine bone had significantly higher PPD (P=0.013) and were more susceptible to develop 
peri-implantitis (OR=4.51; P=0.04) as compared with implants inserted in regenerated bone. 
Accordingly, a similar study found that implants in augmented sites have a lower risk of 
developing peri-implant mucositis when compared with implants placed in non-augmented 
sites. Regenerating the missing bone provides better hard tissue architecture, allowing for 
ideal implant placement. As a consequence, the better adaptation of the hard and soft tissue 
around the implant shoulder might explain a better control against bacterial colonization and 
greater resistance to bacteria, thus decreasing the probability of developing peri-implantitis 
[9]. Other studies failed to demonstrate a similar association between augmentation 
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procedures and implant failures [38,39]. In contrast, from a different cross-sectional study, 
the events of peri-implant mucositis and peri-implantitis appeared to be correlated with 
augmentation procedures. In particular, implants with a fixed prosthesis placed in the 
upper jaw along with bone augmentation procedures appeared to be more susceptible to 
peri-implant diseases [8]. Notably, in our department, augmentation procedures are carried 
out only in non-smoking, healthy patients; this may have had an effect on the outcomes of 
implant therapy.
Within the limitations of the study, subjects aged 65 years or older and non-adherent subjects 
were more prone to developing peri-implant mucositis and peri-implantitis to a degree that 
was statistically significant. At the implant level, the absence of keratinized gingiva, implants 
placed in pristine bone, and peri-implant soft tissue recessions were statistically correlated with 
peri-implant disease. Therefore, early diagnosis of peri-implant mucositis associated with the 
identification of specific risk indicators may prevent subsequent advanced tissue breakdown.
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